Suppr超能文献

路易体病中 tau 病理学的认知和病理影响。

Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.

机构信息

Department of Neurology, Perelman School of Medicine at the University of Pennsylvania.

Digital Neuropathology Laboratory, Perelman School of Medicine at the University of Pennsylvania.

出版信息

Ann Neurol. 2019 Feb;85(2):259-271. doi: 10.1002/ana.25392. Epub 2019 Jan 7.

Abstract

OBJECTIVE

To use digital histology in a large autopsy cohort of Lewy body disorder (LBD) patients with dementia to test the hypotheses that co-occurring Alzheimer disease (AD) pathology impacts the anatomic distribution of α-synuclein (SYN) pathology and that co-occurring neocortical tau pathology in LBDs associates with worse cognitive performance and occurs in a pattern differing from AD.

METHODS

Fifty-five autopsy-confirmed LBD (Parkinson disease with dementia, n = 36; dementia with Lewy bodies, n = 19) patients and 25 AD patients were studied. LBD patients were categorized as having moderate/severe AD copathology (SYN + AD = 20) or little/no AD copathology (SYN-AD = 35). Digital measures of tau, β-amyloid (Aβ), and SYN histopathology in neocortical and subcortical/limbic regions were compared between groups and related to antemortem cognitive testing.

RESULTS

SYN burden was higher in SYN + AD than SYN-AD in each neocortical region (F = 5.6-6.0, p < 0.02) but was equivalent in entorhinal cortex and putamen (F = 0.7-1.7, p > 0.2). SYN + AD performed worse than SYN-AD on a temporal lobe-mediated naming task (t = 2.1, p = 0.04). Antemortem cognitive test scores inversely correlated with tau burden (r = -0.39 to -0.68, p < 0.05). AD had higher tau than SYN + AD in all regions (F = 12.8-97.2, p < 0.001); however, SYN + AD had a greater proportion of tau in the temporal neocortex than AD (t = 2.0, p < 0.05), whereas AD had a greater proportion of tau in the frontal neocortex than SYN + AD (t = 3.3, p < 0.002). SYN + AD had similar severity and distribution of neocortical Aβ compared to AD (F = 1.6-2.0, p > 0.1).

INTERPRETATION

LBD patients with AD copathology harbor greater neocortical SYN pathology. Regional tau pathology relates to cognitive performance in LBD dementia, and its distribution may diverge from pure AD. Tau copathology contributes uniquely to the heterogeneity of cognitive impairment in LBD. Ann Neurol 2018; 1-13 ANN NEUROL 2019;85:259-271.

摘要

目的

利用数字组织病理学方法,在伴有痴呆的路易体障碍(LBD)患者的大型尸检队列中进行研究,以检验以下假设:并存的阿尔茨海默病(AD)病理学影响α-突触核蛋白(SYN)病理学的解剖分布,并存的 LBD 皮质tau 病理学与较差的认知表现相关,其分布模式与 AD 不同。

方法

研究了 55 例经尸检证实的 LBD(帕金森病伴痴呆,n=36;痴呆伴路易体,n=19)患者和 25 例 AD 患者。将 LBD 患者分为 AD 共病(SYN+AD=20 例)或无 AD 共病(SYN-AD=35 例)。比较了各组间皮质和皮质下/边缘区的 tau、β-淀粉样蛋白(Aβ)和 SYN 组织病理学的数字测量值,并与生前认知测试相关。

结果

在每个皮质区域,SYN+AD 的 SYN 负担均高于 SYN-AD(F=5.6-6.0,p<0.02),但在海马旁回和纹状体中无差异(F=0.7-1.7,p>0.2)。SYN+AD 在颞叶介导的命名任务上的表现不如 SYN-AD(t=2.1,p=0.04)。生前认知测试评分与 tau 负担呈负相关(r=-0.39 至-0.68,p<0.05)。所有区域的 AD 患者 tau 水平均高于 SYN+AD(F=12.8-97.2,p<0.001);然而,SYN+AD 患者颞叶皮质中的 tau 比例高于 AD(t=2.0,p<0.05),而 AD 患者额叶皮质中的 tau 比例高于 SYN+AD(t=3.3,p<0.002)。SYN+AD 的皮质 Aβ 严重程度和分布与 AD 相似(F=1.6-2.0,p>0.1)。

结论

伴有 AD 共病的 LBD 患者脑皮质中 SYN 病理学更为严重。皮质 tau 病理学与 LBD 痴呆患者的认知表现有关,其分布可能与单纯 AD 不同。tau 共病是 LBD 认知障碍异质性的独特贡献因素。Ann Neurol 2018;1-13 ANN NEUROL 2019;85:259-271.

相似文献

1
Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.
Ann Neurol. 2019 Feb;85(2):259-271. doi: 10.1002/ana.25392. Epub 2019 Jan 7.
2
Hippocampal subfield pathologic burden in Lewy body diseases vs. Alzheimer's disease.
Neuropathol Appl Neurobiol. 2020 Dec;46(7):707-721. doi: 10.1111/nan.12659. Epub 2020 Sep 24.
3
CSF tau and β-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders.
Neurology. 2018 Mar 20;90(12):e1038-e1046. doi: 10.1212/WNL.0000000000005166. Epub 2018 Feb 21.
4
Tau pathology associates with in vivo cortical thinning in Lewy body disorders.
Ann Clin Transl Neurol. 2020 Dec;7(12):2342-2355. doi: 10.1002/acn3.51183. Epub 2020 Oct 27.
5
Quantifying regional α -synuclein, amyloid β, and tau accumulation in lewy body dementia.
Ann Clin Transl Neurol. 2022 Feb;9(2):106-121. doi: 10.1002/acn3.51482. Epub 2022 Jan 21.
7
Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.
Neuropathol Appl Neurobiol. 2016 Aug;42(5):451-62. doi: 10.1111/nan.12308. Epub 2016 Apr 1.
10
Neuropsychiatric symptoms profile and markers of Alzheimer disease-type pathology in patients with Lewy body dementias.
Brain Res. 2024 Jun 15;1833:148881. doi: 10.1016/j.brainres.2024.148881. Epub 2024 Mar 21.

引用本文的文献

3
Seed Amplification Assay for α-Synuclein: Diagnostic Applications in Synucleinopathies.
Int J Mol Sci. 2025 Aug 13;26(16):7817. doi: 10.3390/ijms26167817.
4
Comorbid Pathologies and Their Impact on Dementia with Lewy Bodies-Current View.
Int J Mol Sci. 2025 Aug 8;26(16):7674. doi: 10.3390/ijms26167674.
5
Lewy body dementia: exploring biomarkers and pathogenic interactions of amyloid β, tau, and α-synuclein.
Mol Neurodegener. 2025 Aug 12;20(1):90. doi: 10.1186/s13024-025-00879-0.
7
Age-related trends in amyloid positivity in Parkinson's disease without dementia.
Aging (Albany NY). 2025 Aug 6;17(8):2015-2032. doi: 10.18632/aging.206297.
9
Accumulation of LRRK2-associated phospho-Rab12 degenerative lysosomes in tauopathies.
bioRxiv. 2025 Jun 9:2025.06.06.658328. doi: 10.1101/2025.06.06.658328.

本文引用的文献

2
Synaptic phosphorylated α-synuclein in dementia with Lewy bodies.
Brain. 2017 Dec 1;140(12):3204-3214. doi: 10.1093/brain/awx275.
3
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.
Neurology. 2017 Jul 4;89(1):88-100. doi: 10.1212/WNL.0000000000004058. Epub 2017 Jun 7.
6
Duration and Pathologic Correlates of Lewy Body Disease.
JAMA Neurol. 2017 Mar 1;74(3):310-315. doi: 10.1001/jamaneurol.2016.4926.
8
AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies.
Ann Neurol. 2017 Jan;81(1):58-67. doi: 10.1002/ana.24825. Epub 2016 Dec 19.
9
Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases.
JAMA Neurol. 2016 Nov 1;73(11):1334-1341. doi: 10.1001/jamaneurol.2016.3338.
10
Arguing against the proposed definition changes of PD.
Mov Disord. 2016 Nov;31(11):1619-1622. doi: 10.1002/mds.26721. Epub 2016 Aug 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验